Rank | Gene Set | Z-score |
---|---|---|
1 | glycosphingolipid catabolic process (GO:0046479) | 5.30386134 |
2 | regulation of mononuclear cell migration (GO:0071675) | 5.20579136 |
3 | oligosaccharide catabolic process (GO:0009313) | 5.10715249 |
4 | glycolipid catabolic process (GO:0019377) | 4.98140615 |
5 | negative regulation of interleukin-12 production (GO:0032695) | 4.69251462 |
6 | response to peptidoglycan (GO:0032494) | 4.60280985 |
7 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.51166929 |
8 | ceramide catabolic process (GO:0046514) | 4.34309664 |
9 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.33600287 |
10 | L-phenylalanine metabolic process (GO:0006558) | 4.32051553 |
11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.32051553 |
12 | sulfur amino acid catabolic process (GO:0000098) | 4.28162126 |
13 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 4.26839655 |
14 | membrane lipid catabolic process (GO:0046466) | 4.26591960 |
15 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.24144921 |
16 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 4.21342234 |
17 | regulation of podosome assembly (GO:0071801) | 4.18962723 |
18 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.15139714 |
19 | amino sugar catabolic process (GO:0046348) | 4.06949811 |
20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.05101887 |
21 | L-phenylalanine catabolic process (GO:0006559) | 4.05101887 |
22 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.04016394 |
23 | T-helper 1 type immune response (GO:0042088) | 4.02732258 |
24 | glyoxylate metabolic process (GO:0046487) | 4.02120656 |
25 | sphingolipid catabolic process (GO:0030149) | 4.00881850 |
26 | lysine metabolic process (GO:0006553) | 4.00475578 |
27 | lysine catabolic process (GO:0006554) | 4.00475578 |
28 | adhesion of symbiont to host cell (GO:0044650) | 3.89997141 |
29 | virion attachment to host cell (GO:0019062) | 3.89997141 |
30 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.84776889 |
31 | regulation of vitamin metabolic process (GO:0030656) | 3.83401896 |
32 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.79271416 |
33 | regulation of cholesterol homeostasis (GO:2000188) | 3.75753521 |
34 | regulation of macrophage chemotaxis (GO:0010758) | 3.70225610 |
35 | monocyte chemotaxis (GO:0002548) | 3.69258005 |
36 | Golgi transport vesicle coating (GO:0048200) | 3.69249417 |
37 | COPI coating of Golgi vesicle (GO:0048205) | 3.69249417 |
38 | regulation of chemokine biosynthetic process (GO:0045073) | 3.67334075 |
39 | tyrosine metabolic process (GO:0006570) | 3.63298325 |
40 | barbed-end actin filament capping (GO:0051016) | 3.63258824 |
41 | response to thyroid hormone (GO:0097066) | 3.55939140 |
42 | NIK/NF-kappaB signaling (GO:0038061) | 3.53097667 |
43 | adhesion of symbiont to host (GO:0044406) | 3.52963100 |
44 | myeloid dendritic cell differentiation (GO:0043011) | 3.51516493 |
45 | cysteine metabolic process (GO:0006534) | 3.51296117 |
46 | positive regulation of heat generation (GO:0031652) | 3.51189186 |
47 | aromatic amino acid family catabolic process (GO:0009074) | 3.50886436 |
48 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.48497147 |
49 | neutrophil activation involved in immune response (GO:0002283) | 3.47415172 |
50 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.45544398 |
51 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.44992090 |
52 | reverse cholesterol transport (GO:0043691) | 3.44162857 |
53 | drug transmembrane transport (GO:0006855) | 3.43610031 |
54 | regulation of fever generation (GO:0031620) | 3.43170791 |
55 | macrophage activation involved in immune response (GO:0002281) | 3.42779275 |
56 | regulation of cholesterol storage (GO:0010885) | 3.39328554 |
57 | 4-hydroxyproline metabolic process (GO:0019471) | 3.38974084 |
58 | N-acetylneuraminate metabolic process (GO:0006054) | 3.38498355 |
59 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.37120386 |
60 | protein carboxylation (GO:0018214) | 3.37120386 |
61 | urate metabolic process (GO:0046415) | 3.36703484 |
62 | protein localization to endosome (GO:0036010) | 3.33361478 |
63 | cellular response to arsenic-containing substance (GO:0071243) | 3.30417256 |
64 | positive regulation of leukocyte degranulation (GO:0043302) | 3.29995679 |
65 | immunoglobulin mediated immune response (GO:0016064) | 3.28615595 |
66 | complement activation, alternative pathway (GO:0006957) | 3.25979913 |
67 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.25877836 |
68 | proline metabolic process (GO:0006560) | 3.25275535 |
69 | amino-acid betaine metabolic process (GO:0006577) | 3.23437637 |
70 | kynurenine metabolic process (GO:0070189) | 3.22090315 |
71 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.22039543 |
72 | regulation of cholesterol esterification (GO:0010872) | 3.21317051 |
73 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.20804658 |
74 | tricarboxylic acid metabolic process (GO:0072350) | 3.20421158 |
75 | homocysteine metabolic process (GO:0050667) | 3.20054712 |
76 | peptide catabolic process (GO:0043171) | 3.19951193 |
77 | cellular modified amino acid catabolic process (GO:0042219) | 3.19532738 |
78 | proline biosynthetic process (GO:0006561) | 3.19081153 |
79 | primary alcohol catabolic process (GO:0034310) | 3.18808394 |
80 | intestinal absorption (GO:0050892) | 3.17595925 |
81 | high-density lipoprotein particle remodeling (GO:0034375) | 3.17067483 |
82 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.16208541 |
83 | intestinal cholesterol absorption (GO:0030299) | 3.15425011 |
84 | phospholipid efflux (GO:0033700) | 3.14457857 |
85 | alpha-linolenic acid metabolic process (GO:0036109) | 3.14427247 |
86 | aromatic amino acid family metabolic process (GO:0009072) | 3.13800297 |
87 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.12857338 |
88 | tryptophan metabolic process (GO:0006568) | 3.12491127 |
89 | serine family amino acid catabolic process (GO:0009071) | 3.10985287 |
90 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.10907733 |
91 | growth hormone receptor signaling pathway (GO:0060396) | 3.10394890 |
92 | low-density lipoprotein particle clearance (GO:0034383) | 3.10077273 |
93 | valine metabolic process (GO:0006573) | 3.06201003 |
94 | tryptophan catabolic process (GO:0006569) | 3.05410681 |
95 | indole-containing compound catabolic process (GO:0042436) | 3.05410681 |
96 | indolalkylamine catabolic process (GO:0046218) | 3.05410681 |
97 | short-chain fatty acid metabolic process (GO:0046459) | 3.03429171 |
98 | hemidesmosome assembly (GO:0031581) | 3.03246697 |
99 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.01884919 |
100 | pinocytosis (GO:0006907) | 3.00383350 |
101 | regulation of protein activation cascade (GO:2000257) | 2.99312677 |
102 | decidualization (GO:0046697) | 2.99269276 |
103 | lipoprotein metabolic process (GO:0042157) | 2.98371499 |
104 | protein retention in ER lumen (GO:0006621) | 2.97676500 |
105 | regulation of apoptotic cell clearance (GO:2000425) | 2.97479933 |
106 | hormone catabolic process (GO:0042447) | 2.97017999 |
107 | regulation of complement activation (GO:0030449) | 2.94931348 |
108 | fatty acid beta-oxidation (GO:0006635) | 2.94628340 |
109 | carnitine metabolic process (GO:0009437) | 2.93186860 |
110 | transcytosis (GO:0045056) | 2.92462818 |
111 | adenosine receptor signaling pathway (GO:0001973) | 2.91691225 |
112 | negative regulation of cholesterol transport (GO:0032375) | 2.91563728 |
113 | negative regulation of sterol transport (GO:0032372) | 2.91563728 |
114 | drug transport (GO:0015893) | 2.90824524 |
115 | regulation of chronic inflammatory response (GO:0002676) | 2.90484706 |
116 | lipid oxidation (GO:0034440) | 2.89613232 |
117 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.89195273 |
118 | plasma lipoprotein particle assembly (GO:0034377) | 2.88897341 |
119 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.88385868 |
120 | plasma lipoprotein particle clearance (GO:0034381) | 2.88294451 |
121 | myeloid dendritic cell activation (GO:0001773) | 2.87688155 |
122 | regulation of superoxide anion generation (GO:0032928) | 2.87390418 |
123 | fatty acid oxidation (GO:0019395) | 2.86041043 |
124 | urea cycle (GO:0000050) | 2.85986140 |
125 | urea metabolic process (GO:0019627) | 2.85986140 |
126 | dendritic cell differentiation (GO:0097028) | 2.85758311 |
127 | protein-lipid complex remodeling (GO:0034368) | 2.84565049 |
128 | macromolecular complex remodeling (GO:0034367) | 2.84565049 |
129 | plasma lipoprotein particle remodeling (GO:0034369) | 2.84565049 |
130 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.83603211 |
131 | 2-oxoglutarate metabolic process (GO:0006103) | 2.80584442 |
132 | eosinophil chemotaxis (GO:0048245) | 2.79908876 |
133 | regulation of mast cell degranulation (GO:0043304) | 2.79061161 |
134 | apoptotic cell clearance (GO:0043277) | 2.78723806 |
135 | flavonoid metabolic process (GO:0009812) | 2.78300515 |
136 | triglyceride homeostasis (GO:0070328) | 2.78257393 |
137 | acylglycerol homeostasis (GO:0055090) | 2.78257393 |
138 | regulation of monocyte chemotaxis (GO:0090025) | 2.77308906 |
139 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.76937767 |
140 | aspartate family amino acid catabolic process (GO:0009068) | 2.76619537 |
141 | ethanol metabolic process (GO:0006067) | 2.75872573 |
142 | sphingosine metabolic process (GO:0006670) | 2.75582316 |
143 | cellular response to lipopolysaccharide (GO:0071222) | 2.75573490 |
144 | negative regulation of lipid storage (GO:0010888) | 2.75059678 |
145 | regulation of early endosome to late endosome transport (GO:2000641) | 2.73504836 |
146 | regulation of interferon-alpha production (GO:0032647) | 2.73008406 |
147 | regulation of triglyceride catabolic process (GO:0010896) | 2.72338244 |
148 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.71889183 |
149 | response to growth hormone (GO:0060416) | 2.70152761 |
150 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.70010567 |
151 | regulation of leukocyte degranulation (GO:0043300) | 2.69896385 |
152 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.69693765 |
153 | melanin biosynthetic process (GO:0042438) | 2.68760379 |
154 | modulation by symbiont of host defense response (GO:0052031) | 2.68652006 |
155 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.68652006 |
156 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.68652006 |
157 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.68652006 |
158 | modulation by symbiont of host immune response (GO:0052553) | 2.68652006 |
159 | positive regulation by symbiont of host defense response (GO:0052509) | 2.68652006 |
160 | renal absorption (GO:0070293) | 2.68621538 |
161 | glial cell migration (GO:0008347) | 2.67548804 |
162 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.66697177 |
163 | ketone body metabolic process (GO:1902224) | 2.66436349 |
164 | positive regulation of interleukin-6 production (GO:0032755) | 2.66264682 |
165 | ethanol oxidation (GO:0006069) | 2.66208977 |
166 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.65298978 |
167 | drug catabolic process (GO:0042737) | 2.65070861 |
168 | response to mercury ion (GO:0046689) | 2.64652885 |
169 | gap junction assembly (GO:0016264) | 2.64586295 |
170 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.64243420 |
171 | protein-lipid complex assembly (GO:0065005) | 2.64088754 |
172 | nitrogen cycle metabolic process (GO:0071941) | 2.64017067 |
173 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.63967954 |
174 | macrophage differentiation (GO:0030225) | 2.63751436 |
175 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.63324478 |
176 | positive regulation of extracellular matrix organization (GO:1903055) | 2.63280690 |
177 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.63149076 |
178 | positive regulation of antigen processing and presentation (GO:0002579) | 2.63114221 |
179 | sterol homeostasis (GO:0055092) | 2.62290677 |
180 | cholesterol homeostasis (GO:0042632) | 2.62147719 |
181 | cellular amino acid catabolic process (GO:0009063) | 2.61662388 |
182 | cellular response to growth hormone stimulus (GO:0071378) | 2.61176024 |
183 | cellular response to molecule of bacterial origin (GO:0071219) | 2.61020727 |
184 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.60788542 |
185 | alpha-amino acid catabolic process (GO:1901606) | 2.60394208 |
186 | cyclooxygenase pathway (GO:0019371) | 2.60374279 |
187 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.59634901 |
188 | positive regulation of mast cell degranulation (GO:0043306) | 2.59050300 |
189 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.59050300 |
190 | aldehyde catabolic process (GO:0046185) | 2.58279249 |
191 | response to protozoan (GO:0001562) | 2.57138818 |
192 | hyaluronan catabolic process (GO:0030214) | 2.56826728 |
193 | regulation of antigen processing and presentation (GO:0002577) | 2.56190750 |
194 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.55960419 |
195 | modulation by symbiont of host cellular process (GO:0044068) | 2.55630145 |
196 | diol metabolic process (GO:0034311) | 2.55172232 |
197 | response to acidic pH (GO:0010447) | 2.53213073 |
198 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.51773025 |
199 | granulocyte activation (GO:0036230) | 2.51583013 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.11084629 |
2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.25159621 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.42649289 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.31083714 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.00780032 |
6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.56033706 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.68284282 |
8 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.55644935 |
9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.38940908 |
10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.29046467 |
11 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.27645265 |
12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.27618233 |
13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.24275436 |
14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.17122784 |
15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.15691795 |
16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.15239993 |
17 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.11565456 |
18 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.04256789 |
19 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.02260482 |
20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.96422967 |
21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.96253655 |
22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.94681559 |
23 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.93638198 |
24 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.91304644 |
25 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.87181021 |
26 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.86003390 |
27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.83889690 |
28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.81055785 |
29 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.78416970 |
30 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.77941784 |
31 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.67859315 |
32 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.67835222 |
33 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.67753870 |
34 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.66701907 |
35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.66649576 |
36 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.64366379 |
37 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.64089470 |
38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.63038724 |
39 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.62174149 |
40 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.60968168 |
41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.60486561 |
42 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.58331929 |
43 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.56234005 |
44 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.56234005 |
45 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.56234005 |
46 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.55237601 |
47 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.54988254 |
48 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.50715769 |
49 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.50327121 |
50 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47722583 |
51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.46062589 |
52 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.43151936 |
53 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.43009288 |
54 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.42687119 |
55 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41363084 |
56 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.41291353 |
57 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.40698353 |
58 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.40284942 |
59 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.39293243 |
60 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38333816 |
61 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36212699 |
62 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.35506230 |
63 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.35148862 |
64 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.34616741 |
65 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.33699061 |
66 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.33486082 |
67 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32120524 |
68 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.29929974 |
69 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.27905870 |
70 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.26033806 |
71 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.23680646 |
72 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.22602069 |
73 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.22507922 |
74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21491701 |
75 | ATF3_27146783_Chip-Seq_COLON_Human | 1.21075338 |
76 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.20332028 |
77 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20003867 |
78 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18602339 |
79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17849591 |
80 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.15991690 |
81 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.15783620 |
82 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.15755096 |
83 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.15386643 |
84 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.14497779 |
85 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14446573 |
86 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.13741963 |
87 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.13677692 |
88 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.12704671 |
89 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.10304248 |
90 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.08862513 |
91 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08750779 |
92 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08268466 |
93 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06004511 |
94 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.05900736 |
95 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04666304 |
96 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04313509 |
97 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.04039643 |
98 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.03611269 |
99 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02150007 |
100 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.01908783 |
101 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.00995706 |
102 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00882364 |
103 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00757810 |
104 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.00173452 |
105 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.00091788 |
106 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99346449 |
107 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98567277 |
108 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.98170424 |
109 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.98095660 |
110 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.98067422 |
111 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.97566146 |
112 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97236549 |
113 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.96974757 |
114 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95788375 |
115 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.95388381 |
116 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.95010790 |
117 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.94373953 |
118 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94344495 |
119 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94321429 |
120 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.93859675 |
121 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.92903684 |
122 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.92903684 |
123 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92667351 |
124 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.92305961 |
125 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.91275121 |
126 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90859424 |
127 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.89310409 |
128 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.87547556 |
129 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.86654984 |
130 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.86631459 |
131 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85301174 |
132 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.85294690 |
133 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.84744088 |
134 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.84744088 |
135 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83813937 |
136 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.82720437 |
137 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.82340702 |
138 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81559159 |
139 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.81405174 |
140 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.80997612 |
141 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.80696492 |
142 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.80642774 |
143 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.80349752 |
144 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.79897876 |
145 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.79811842 |
146 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.77896187 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 4.50690751 |
2 | MP0002139_abnormal_hepatobiliary_system | 4.24179902 |
3 | MP0002138_abnormal_hepatobiliary_system | 3.78453688 |
4 | MP0006082_CNS_inflammation | 3.45395669 |
5 | MP0005365_abnormal_bile_salt | 3.25913398 |
6 | MP0005085_abnormal_gallbladder_physiolo | 3.21785444 |
7 | MP0002148_abnormal_hypersensitivity_rea | 3.06072427 |
8 | MP0009840_abnormal_foam_cell | 3.04785528 |
9 | MP0004510_myositis | 2.96314504 |
10 | MP0003806_abnormal_nucleotide_metabolis | 2.83929863 |
11 | MP0000343_altered_response_to | 2.54800114 |
12 | MP0002254_reproductive_system_inflammat | 2.53225931 |
13 | MP0009785_altered_susceptibility_to | 2.49954626 |
14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.41496482 |
15 | MP0005058_abnormal_lysosome_morphology | 2.30973536 |
16 | MP0003705_abnormal_hypodermis_morpholog | 2.28144338 |
17 | MP0001666_abnormal_nutrient_absorption | 2.26772734 |
18 | MP0005332_abnormal_amino_acid | 2.25257835 |
19 | MP0010234_abnormal_vibrissa_follicle | 2.23777283 |
20 | MP0004019_abnormal_vitamin_homeostasis | 2.21800932 |
21 | MP0005083_abnormal_biliary_tract | 2.21644076 |
22 | MP0002419_abnormal_innate_immunity | 2.19518731 |
23 | MP0003252_abnormal_bile_duct | 2.18438084 |
24 | MP0003195_calcinosis | 2.16845746 |
25 | MP0009643_abnormal_urine_homeostasis | 2.10387167 |
26 | MP0004264_abnormal_extraembryonic_tissu | 2.10192009 |
27 | MP0005451_abnormal_body_composition | 2.09697765 |
28 | MP0010329_abnormal_lipoprotein_level | 2.08883820 |
29 | MP0008004_abnormal_stomach_pH | 2.04126002 |
30 | MP0003300_gastrointestinal_ulcer | 1.95235840 |
31 | MP0003724_increased_susceptibility_to | 1.94280928 |
32 | MP0001790_abnormal_immune_system | 1.90706044 |
33 | MP0005387_immune_system_phenotype | 1.90706044 |
34 | MP0002998_abnormal_bone_remodeling | 1.89488376 |
35 | MP0002877_abnormal_melanocyte_morpholog | 1.86279054 |
36 | MP0005025_abnormal_response_to | 1.85326518 |
37 | MP0005000_abnormal_immune_tolerance | 1.81290912 |
38 | MP0001533_abnormal_skeleton_physiology | 1.80676364 |
39 | MP0001756_abnormal_urination | 1.76938276 |
40 | MP0003566_abnormal_cell_adhesion | 1.69342255 |
41 | MP0003191_abnormal_cellular_cholesterol | 1.65551752 |
42 | MP0005671_abnormal_response_to | 1.64461813 |
43 | MP0000858_altered_metastatic_potential | 1.62045817 |
44 | MP0001835_abnormal_antigen_presentation | 1.61478250 |
45 | MP0003448_altered_tumor_morphology | 1.61017042 |
46 | MP0004043_abnormal_pH_regulation | 1.58019605 |
47 | MP0009278_abnormal_bone_marrow | 1.57361591 |
48 | MP0002452_abnormal_antigen_presenting | 1.53810506 |
49 | MP0000372_irregular_coat_pigmentation | 1.52464840 |
50 | MP0005408_hypopigmentation | 1.50157067 |
51 | MP0005310_abnormal_salivary_gland | 1.45740272 |
52 | MP0000685_abnormal_immune_system | 1.45563279 |
53 | MP0005257_abnormal_intraocular_pressure | 1.45308806 |
54 | MP0005166_decreased_susceptibility_to | 1.44083465 |
55 | MP0003690_abnormal_glial_cell | 1.42536647 |
56 | MP0005377_hearing/vestibular/ear_phenot | 1.41587527 |
57 | MP0003878_abnormal_ear_physiology | 1.41587527 |
58 | MP0005319_abnormal_enzyme/_coenzyme | 1.41426770 |
59 | MP0002723_abnormal_immune_serum | 1.38442619 |
60 | MP0004272_abnormal_basement_membrane | 1.36158178 |
61 | MP0000609_abnormal_liver_physiology | 1.35314122 |
62 | MP0002796_impaired_skin_barrier | 1.32283281 |
63 | MP0003183_abnormal_peptide_metabolism | 1.31586762 |
64 | MP0002136_abnormal_kidney_physiology | 1.26926888 |
65 | MP0002118_abnormal_lipid_homeostasis | 1.22500409 |
66 | MP0005084_abnormal_gallbladder_morpholo | 1.20089907 |
67 | MP0003186_abnormal_redox_activity | 1.18765807 |
68 | MP0002405_respiratory_system_inflammati | 1.15916033 |
69 | MP0003329_amyloid_beta_deposits | 1.12090591 |
70 | MP0009333_abnormal_splenocyte_physiolog | 1.10137018 |
71 | MP0001545_abnormal_hematopoietic_system | 1.09963427 |
72 | MP0005397_hematopoietic_system_phenotyp | 1.09963427 |
73 | MP0005464_abnormal_platelet_physiology | 1.08134328 |
74 | MP0001819_abnormal_immune_cell | 1.06199960 |
75 | MP0000920_abnormal_myelination | 1.06076899 |
76 | MP0003091_abnormal_cell_migration | 1.05378506 |
77 | MP0002420_abnormal_adaptive_immunity | 1.04039584 |
78 | MP0001800_abnormal_humoral_immune | 1.03286870 |
79 | MP0005164_abnormal_response_to | 1.01936587 |
80 | MP0000371_diluted_coat_color | 1.01401166 |
81 | MP0005636_abnormal_mineral_homeostasis | 1.00701779 |
82 | MP0005165_increased_susceptibility_to | 0.99377323 |
83 | MP0008961_abnormal_basal_metabolism | 0.98763967 |
84 | MP0008260_abnormal_autophagy | 0.98685652 |
85 | MP0003453_abnormal_keratinocyte_physiol | 0.98478775 |
86 | MP0010307_abnormal_tumor_latency | 0.96028315 |
87 | MP0000538_abnormal_urinary_bladder | 0.95485115 |
88 | MP0001765_abnormal_ion_homeostasis | 0.95291753 |
89 | MP0003303_peritoneal_inflammation | 0.94772188 |
90 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.94708699 |
91 | MP0005220_abnormal_exocrine_pancreas | 0.92064754 |
92 | MP0004858_abnormal_nervous_system | 0.91746164 |
93 | MP0005023_abnormal_wound_healing | 0.91337843 |
94 | MP0000598_abnormal_liver_morphology | 0.89552176 |
95 | MP0010352_gastrointestinal_tract_polyps | 0.88765592 |
96 | MP0003634_abnormal_glial_cell | 0.88583034 |
97 | MP0001542_abnormal_bone_strength | 0.88468080 |
98 | MP0003075_altered_response_to | 0.88260812 |
99 | MP0005076_abnormal_cell_differentiation | 0.87064262 |
100 | MP0005670_abnormal_white_adipose | 0.86974105 |
101 | MP0003172_abnormal_lysosome_physiology | 0.86848000 |
102 | MP0003638_abnormal_response/metabolism_ | 0.86810095 |
103 | MP0001849_ear_inflammation | 0.86024162 |
104 | MP0005595_abnormal_vascular_smooth | 0.85644813 |
105 | MP0005390_skeleton_phenotype | 0.85643544 |
106 | MP0009384_cardiac_valve_regurgitation | 0.82483043 |
107 | MP0002090_abnormal_vision | 0.80312561 |
108 | MP0008469_abnormal_protein_level | 0.78452454 |
109 | MP0003436_decreased_susceptibility_to | 0.78305292 |
110 | MP0002896_abnormal_bone_mineralization | 0.76423424 |
111 | MP0003795_abnormal_bone_structure | 0.76118997 |
112 | MP0002332_abnormal_exercise_endurance | 0.75769083 |
113 | MP0003656_abnormal_erythrocyte_physiolo | 0.75700886 |
114 | MP0005167_abnormal_blood-brain_barrier | 0.75458359 |
115 | MP0004947_skin_inflammation | 0.75339385 |
116 | MP0000604_amyloidosis | 0.74732476 |
117 | MP0010386_abnormal_urinary_bladder | 0.74443701 |
118 | MP0001873_stomach_inflammation | 0.73621794 |
119 | MP0003279_aneurysm | 0.73458106 |
120 | MP0002078_abnormal_glucose_homeostasis | 0.73258575 |
121 | MP0000490_abnormal_crypts_of | 0.72997608 |
122 | MP0001853_heart_inflammation | 0.72592671 |
123 | MP0009763_increased_sensitivity_to | 0.71357931 |
124 | MP0003941_abnormal_skin_development | 0.71231647 |
125 | MP0003828_pulmonary_edema | 0.70382224 |
126 | MP0002277_abnormal_respiratory_mucosa | 0.70243635 |
127 | MP0009764_decreased_sensitivity_to | 0.70164916 |
128 | MP0002928_abnormal_bile_duct | 0.69046129 |
129 | MP0005666_abnormal_adipose_tissue | 0.68720420 |
130 | MP0003950_abnormal_plasma_membrane | 0.68110888 |
131 | MP0002098_abnormal_vibrissa_morphology | 0.67362840 |
132 | MP0009642_abnormal_blood_homeostasis | 0.67078887 |
133 | MP0000462_abnormal_digestive_system | 0.66953428 |
134 | MP0003283_abnormal_digestive_organ | 0.66810489 |
135 | MP0004084_abnormal_cardiac_muscle | 0.65714746 |
136 | MP0010368_abnormal_lymphatic_system | 0.64848901 |
137 | MP0000716_abnormal_immune_system | 0.64569941 |
138 | MP0002089_abnormal_postnatal_growth/wei | 0.63627050 |
139 | MP0006054_spinal_hemorrhage | 0.63016183 |
140 | MP0001845_abnormal_inflammatory_respons | 0.62116772 |
141 | MP0002135_abnormal_kidney_morphology | 0.61747754 |
142 | MP0001944_abnormal_pancreas_morphology | 0.61710343 |
143 | MP0002972_abnormal_cardiac_muscle | 0.61640661 |
144 | MP0002909_abnormal_adrenal_gland | 0.61466204 |
145 | MP0004185_abnormal_adipocyte_glucose | 0.59798261 |
146 | MP0005248_abnormal_Harderian_gland | 0.59686987 |
147 | MP0001764_abnormal_homeostasis | 0.59595796 |
148 | MP0002127_abnormal_cardiovascular_syste | 0.58690521 |
149 | MP0001216_abnormal_epidermal_layer | 0.58374028 |
150 | MP0005501_abnormal_skin_physiology | 0.57680984 |
151 | MP0000249_abnormal_blood_vessel | 0.57185590 |
152 | MP0000230_abnormal_systemic_arterial | 0.56570192 |
153 | MP0002060_abnormal_skin_morphology | 0.56411191 |
154 | MP0001663_abnormal_digestive_system | 0.56240776 |
155 | MP0010155_abnormal_intestine_physiology | 0.56099201 |
156 | MP0005381_digestive/alimentary_phenotyp | 0.55955602 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of glycolipid metabolism (HP:0010969) | 8.60875132 |
2 | Abnormality of liposaccharide metabolism (HP:0010968) | 8.60875132 |
3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 8.60875132 |
4 | Increased cerebral lipofuscin (HP:0011813) | 5.56111708 |
5 | Disinhibition (HP:0000734) | 5.14707298 |
6 | Loss of speech (HP:0002371) | 5.07630475 |
7 | Axonal loss (HP:0003447) | 4.57801813 |
8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.52450517 |
9 | Nuclear cataract (HP:0100018) | 4.47447210 |
10 | Hypoglycemic coma (HP:0001325) | 4.34266532 |
11 | Neurofibrillary tangles (HP:0002185) | 4.20927420 |
12 | Abnormality of macrophages (HP:0004311) | 4.15714907 |
13 | Mutism (HP:0002300) | 4.14350603 |
14 | Systemic lupus erythematosus (HP:0002725) | 4.05078701 |
15 | Ketoacidosis (HP:0001993) | 3.93056334 |
16 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.89606713 |
17 | Xanthomatosis (HP:0000991) | 3.82042491 |
18 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.75488892 |
19 | Gout (HP:0001997) | 3.68407290 |
20 | Intrahepatic cholestasis (HP:0001406) | 3.66355598 |
21 | Vacuolated lymphocytes (HP:0001922) | 3.60265728 |
22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.52871131 |
23 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.51571751 |
24 | Late onset (HP:0003584) | 3.50031627 |
25 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.43560920 |
26 | Mucopolysacchariduria (HP:0008155) | 3.40145889 |
27 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.40145889 |
28 | Complement deficiency (HP:0004431) | 3.38357897 |
29 | Ketosis (HP:0001946) | 3.35074735 |
30 | Dysostosis multiplex (HP:0000943) | 3.31777402 |
31 | Right ventricular cardiomyopathy (HP:0011663) | 3.31243695 |
32 | Hyperglycinuria (HP:0003108) | 3.29246394 |
33 | Hypoglycemic seizures (HP:0002173) | 3.25992546 |
34 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.21582196 |
35 | Cerebral inclusion bodies (HP:0100314) | 3.18186327 |
36 | Upper motor neuron abnormality (HP:0002127) | 3.14874776 |
37 | Apathy (HP:0000741) | 3.13470682 |
38 | Deep venous thrombosis (HP:0002625) | 3.08970349 |
39 | Diminished motivation (HP:0000745) | 3.07908327 |
40 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.03850529 |
41 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.03850529 |
42 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.03850529 |
43 | Hyperammonemia (HP:0001987) | 3.01796199 |
44 | Esophageal varix (HP:0002040) | 2.95619064 |
45 | Progressive neurologic deterioration (HP:0002344) | 2.93416471 |
46 | Recurrent bacterial skin infections (HP:0005406) | 2.92765238 |
47 | Abnormality of purine metabolism (HP:0004352) | 2.91864423 |
48 | Agnosia (HP:0010524) | 2.90704095 |
49 | Asymmetric septal hypertrophy (HP:0001670) | 2.89776183 |
50 | Abnormality of complement system (HP:0005339) | 2.86316162 |
51 | Recurrent abscess formation (HP:0002722) | 2.81551648 |
52 | Inappropriate behavior (HP:0000719) | 2.79448767 |
53 | Metaphyseal irregularity (HP:0003025) | 2.78988102 |
54 | Neuronal loss in central nervous system (HP:0002529) | 2.77611031 |
55 | Prolonged neonatal jaundice (HP:0006579) | 2.76453992 |
56 | Hydroxyprolinuria (HP:0003080) | 2.68436022 |
57 | Abnormality of proline metabolism (HP:0010907) | 2.68436022 |
58 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.66785348 |
59 | Eczematoid dermatitis (HP:0000976) | 2.66189301 |
60 | Malnutrition (HP:0004395) | 2.65232188 |
61 | Proximal tubulopathy (HP:0000114) | 2.56674394 |
62 | Hematochezia (HP:0002573) | 2.56228483 |
63 | Glomerulonephritis (HP:0000099) | 2.54117071 |
64 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.52886743 |
65 | Abnormality of glycine metabolism (HP:0010895) | 2.52886743 |
66 | Hypobetalipoproteinemia (HP:0003563) | 2.52164781 |
67 | Symptomatic seizures (HP:0011145) | 2.51766631 |
68 | Purpura (HP:0000979) | 2.51563773 |
69 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.51137783 |
70 | Generalized aminoaciduria (HP:0002909) | 2.48781071 |
71 | Pathologic fracture (HP:0002756) | 2.46876178 |
72 | Dementia (HP:0000726) | 2.46199491 |
73 | Personality changes (HP:0000751) | 2.46093960 |
74 | Abnormality of nucleobase metabolism (HP:0010932) | 2.45623906 |
75 | Increased serum ferritin (HP:0003281) | 2.45302600 |
76 | Abnormality of chloride homeostasis (HP:0011422) | 2.37961214 |
77 | Fat malabsorption (HP:0002630) | 2.36080598 |
78 | Vertebral compression fractures (HP:0002953) | 2.34437308 |
79 | Hyperactive renin-angiotensin system (HP:0000841) | 2.33607348 |
80 | Abnormality of the intrinsic pathway (HP:0010989) | 2.32589662 |
81 | Vascular calcification (HP:0004934) | 2.29742339 |
82 | Mediastinal lymphadenopathy (HP:0100721) | 2.29698329 |
83 | Hepatocellular carcinoma (HP:0001402) | 2.27193595 |
84 | Conjunctival telangiectasia (HP:0000524) | 2.26231849 |
85 | Orchitis (HP:0100796) | 2.26195283 |
86 | Abnormality of the common coagulation pathway (HP:0010990) | 2.24422284 |
87 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.23191200 |
88 | Hyperglycemia (HP:0003074) | 2.22274823 |
89 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.21952243 |
90 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.21952243 |
91 | Bone pain (HP:0002653) | 2.21637531 |
92 | Cardiomegaly (HP:0001640) | 2.21617345 |
93 | Hyperglycinemia (HP:0002154) | 2.21406209 |
94 | Ventricular tachycardia (HP:0004756) | 2.18050965 |
95 | Prolonged partial thromboplastin time (HP:0003645) | 2.15669763 |
96 | Hyperuricemia (HP:0002149) | 2.15656910 |
97 | Increased purine levels (HP:0004368) | 2.15656910 |
98 | Hepatosplenomegaly (HP:0001433) | 2.14428218 |
99 | Nausea (HP:0002018) | 2.14215190 |
100 | Retinal atrophy (HP:0001105) | 2.10871329 |
101 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.10520711 |
102 | Hypolipoproteinemia (HP:0010981) | 2.09968932 |
103 | Myocardial infarction (HP:0001658) | 2.09679600 |
104 | J-shaped sella turcica (HP:0002680) | 2.08194233 |
105 | Peripheral demyelination (HP:0011096) | 2.07497580 |
106 | Abdominal distention (HP:0003270) | 2.05360278 |
107 | Sensorimotor neuropathy (HP:0007141) | 2.04225151 |
108 | Abnormality of urine glucose concentration (HP:0011016) | 2.03709121 |
109 | Glycosuria (HP:0003076) | 2.03709121 |
110 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.03171792 |
111 | Basal ganglia calcification (HP:0002135) | 2.03078826 |
112 | Thoracic kyphosis (HP:0002942) | 2.02850091 |
113 | Joint hemorrhage (HP:0005261) | 2.02223280 |
114 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.01487797 |
115 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.01411865 |
116 | Myoglobinuria (HP:0002913) | 2.01348019 |
117 | Abnormal hemoglobin (HP:0011902) | 1.99302444 |
118 | Hypercholesterolemia (HP:0003124) | 1.99193988 |
119 | Spastic diplegia (HP:0001264) | 1.98968191 |
120 | Nephritis (HP:0000123) | 1.98818524 |
121 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.98511829 |
122 | Amyloidosis (HP:0011034) | 1.97259135 |
123 | Back pain (HP:0003418) | 1.97106109 |
124 | Retrobulbar optic neuritis (HP:0100654) | 1.95338349 |
125 | Optic neuritis (HP:0100653) | 1.95338349 |
126 | Cardiovascular calcification (HP:0011915) | 1.95224033 |
127 | Skin nodule (HP:0200036) | 1.92967327 |
128 | Abnormality of renal excretion (HP:0011036) | 1.92566662 |
129 | Dicarboxylic aciduria (HP:0003215) | 1.92144313 |
130 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.92144313 |
131 | Polycythemia (HP:0001901) | 1.92068997 |
132 | Hypoalphalipoproteinemia (HP:0003233) | 1.91780230 |
133 | Epidermoid cyst (HP:0200040) | 1.91431253 |
134 | Mesangial abnormality (HP:0001966) | 1.90717887 |
135 | Tetraparesis (HP:0002273) | 1.90295394 |
136 | Protuberant abdomen (HP:0001538) | 1.89794994 |
137 | Achilles tendon contracture (HP:0001771) | 1.89586525 |
138 | Supranuclear gaze palsy (HP:0000605) | 1.89024293 |
139 | Multiple enchondromatosis (HP:0005701) | 1.88865083 |
140 | Irritability (HP:0000737) | 1.87949410 |
141 | Abnormal urine output (HP:0012590) | 1.87307869 |
142 | Hyperlipoproteinemia (HP:0010980) | 1.87037875 |
143 | Alkalosis (HP:0001948) | 1.85380084 |
144 | Beaking of vertebral bodies (HP:0004568) | 1.84472235 |
145 | Palpitations (HP:0001962) | 1.84396329 |
146 | Interstitial pulmonary disease (HP:0006530) | 1.83640433 |
147 | Onycholysis (HP:0001806) | 1.83340740 |
148 | Global brain atrophy (HP:0002283) | 1.83156536 |
149 | Petechiae (HP:0000967) | 1.82984127 |
150 | Hypokalemic alkalosis (HP:0001949) | 1.82650030 |
151 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.82388740 |
152 | Abnormality of the nasal mucosa (HP:0000433) | 1.82035147 |
153 | Zonular cataract (HP:0010920) | 1.81304996 |
154 | Autoimmune thrombocytopenia (HP:0001973) | 1.81212492 |
155 | Pustule (HP:0200039) | 1.81058966 |
156 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.80791553 |
157 | Myositis (HP:0100614) | 1.80366076 |
158 | Hand muscle atrophy (HP:0009130) | 1.78974449 |
159 | Progressive visual loss (HP:0000529) | 1.78920309 |
160 | Abnormality of the lumbar spine (HP:0100712) | 1.74156814 |
161 | Abnormality of the Achilles tendon (HP:0005109) | 1.72591266 |
162 | Abnormality of iron homeostasis (HP:0011031) | 1.71244746 |
163 | Spontaneous hematomas (HP:0007420) | 1.69004712 |
164 | Stomatitis (HP:0010280) | 1.67628709 |
165 | Polyneuropathy (HP:0001271) | 1.66802016 |
166 | Spondylolisthesis (HP:0003302) | 1.66484091 |
167 | Increased CSF protein (HP:0002922) | 1.63046743 |
168 | Urinary incontinence (HP:0000020) | 1.61360057 |
169 | Memory impairment (HP:0002354) | 1.56741862 |
170 | Polygenic inheritance (HP:0010982) | 1.55964216 |
171 | Gingivitis (HP:0000230) | 1.55698806 |
172 | Mucosal telangiectasiae (HP:0100579) | 1.55660441 |
173 | Hyperparathyroidism (HP:0000843) | 1.54126733 |
174 | Thin bony cortex (HP:0002753) | 1.53877929 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NME2 | 4.93168769 |
2 | MST1R | 4.20275289 |
3 | ERN1 | 3.79794188 |
4 | TRIB3 | 2.96637503 |
5 | GRK7 | 2.91934618 |
6 | BCKDK | 2.81363580 |
7 | EPHA2 | 2.74950288 |
8 | MAPK15 | 2.73384572 |
9 | TAOK2 | 2.51618441 |
10 | MYLK | 2.37736603 |
11 | MET | 2.26257672 |
12 | ACVR1B | 2.13083368 |
13 | TAOK1 | 2.12007773 |
14 | LMTK2 | 2.11539718 |
15 | PKN2 | 2.09775267 |
16 | FGFR4 | 2.09023254 |
17 | FGR | 2.03749883 |
18 | WNK4 | 2.01856716 |
19 | MAP2K2 | 1.99650922 |
20 | PTK6 | 1.96912287 |
21 | TYK2 | 1.92387367 |
22 | RIPK1 | 1.90558974 |
23 | WNK3 | 1.73852013 |
24 | SIK1 | 1.72752806 |
25 | EPHB1 | 1.70297307 |
26 | INSRR | 1.67393651 |
27 | MOS | 1.60528341 |
28 | MST4 | 1.59921363 |
29 | PTK2 | 1.51251711 |
30 | MATK | 1.47917745 |
31 | TAOK3 | 1.46599029 |
32 | PRPF4B | 1.44620280 |
33 | PDGFRA | 1.42392525 |
34 | MAP3K2 | 1.40471116 |
35 | FLT3 | 1.39235007 |
36 | BMX | 1.38443782 |
37 | LATS2 | 1.33217027 |
38 | TESK1 | 1.32689625 |
39 | LRRK2 | 1.29065233 |
40 | IRAK4 | 1.28962313 |
41 | EPHA3 | 1.27317372 |
42 | TBK1 | 1.27297183 |
43 | MAP3K13 | 1.26473971 |
44 | MAP3K3 | 1.23278322 |
45 | FRK | 1.23053690 |
46 | ADRBK2 | 1.22003877 |
47 | SCYL2 | 1.19182516 |
48 | ARAF | 1.12994081 |
49 | ICK | 1.12517541 |
50 | PIK3CG | 1.09150900 |
51 | TESK2 | 1.08468113 |
52 | KDR | 1.06139685 |
53 | CSK | 1.06105550 |
54 | CAMK1D | 1.04976012 |
55 | STK38L | 1.04809602 |
56 | CSF1R | 1.04425979 |
57 | MAP3K14 | 0.98655841 |
58 | GRK6 | 0.98649602 |
59 | PRKG2 | 0.97665592 |
60 | BLK | 0.96610591 |
61 | MAP3K11 | 0.95542693 |
62 | DYRK1B | 0.94661223 |
63 | PAK4 | 0.93018950 |
64 | TGFBR2 | 0.91537433 |
65 | FER | 0.89950836 |
66 | TTN | 0.89441628 |
67 | TGFBR1 | 0.88388450 |
68 | MAPKAPK3 | 0.86053568 |
69 | ERBB4 | 0.85558647 |
70 | NEK9 | 0.85423994 |
71 | KIT | 0.83539932 |
72 | DDR2 | 0.83182231 |
73 | LIMK1 | 0.79823193 |
74 | TYRO3 | 0.79655498 |
75 | JAK2 | 0.76962337 |
76 | JAK1 | 0.75607285 |
77 | MAP2K1 | 0.74711198 |
78 | IRAK2 | 0.74414139 |
79 | MARK3 | 0.73418258 |
80 | GSK3A | 0.73237357 |
81 | STK10 | 0.72697539 |
82 | CDC42BPA | 0.72635400 |
83 | MAP3K1 | 0.69231049 |
84 | JAK3 | 0.68967459 |
85 | STK24 | 0.66491032 |
86 | EPHB2 | 0.65609003 |
87 | ZAP70 | 0.64671105 |
88 | CAMKK2 | 0.63988629 |
89 | LATS1 | 0.63710723 |
90 | MAP3K9 | 0.63636869 |
91 | DAPK3 | 0.63504316 |
92 | CHUK | 0.60584712 |
93 | MAP2K3 | 0.59810505 |
94 | RPS6KA4 | 0.59205581 |
95 | IRAK3 | 0.59159576 |
96 | NTRK1 | 0.58706063 |
97 | BMPR2 | 0.56779279 |
98 | PASK | 0.55236954 |
99 | KSR2 | 0.52841953 |
100 | MAP2K6 | 0.52302927 |
101 | MAPK11 | 0.51883216 |
102 | CDK6 | 0.50925412 |
103 | LYN | 0.48377406 |
104 | ABL2 | 0.48121557 |
105 | PRKD2 | 0.47040636 |
106 | TRPM7 | 0.46226125 |
107 | NEK1 | 0.44886846 |
108 | RIPK4 | 0.44575635 |
109 | DMPK | 0.44326670 |
110 | TIE1 | 0.42732225 |
111 | SIK3 | 0.42220225 |
112 | PRKAA2 | 0.41990187 |
113 | HIPK2 | 0.41934137 |
114 | EGFR | 0.41467091 |
115 | MAP3K5 | 0.40305262 |
116 | MAP4K1 | 0.40056796 |
117 | MAP3K8 | 0.39911310 |
118 | CAMK1G | 0.39091706 |
119 | IKBKE | 0.38135812 |
120 | RPS6KA2 | 0.36955689 |
121 | ILK | 0.36707870 |
122 | IKBKB | 0.36339197 |
123 | OBSCN | 0.36259938 |
124 | ERBB2 | 0.35612691 |
125 | PDPK1 | 0.35585467 |
126 | IGF1R | 0.35386044 |
127 | IRAK1 | 0.35073572 |
128 | RPS6KB2 | 0.35049770 |
129 | RPS6KL1 | 0.33229171 |
130 | RPS6KC1 | 0.33229171 |
131 | BRAF | 0.33144010 |
132 | PHKG1 | 0.32294786 |
133 | PHKG2 | 0.32294786 |
134 | NUAK1 | 0.32232349 |
135 | PDGFRB | 0.32094417 |
136 | PAK2 | 0.31922260 |
137 | PIM1 | 0.31688738 |
138 | MAPKAPK2 | 0.31172911 |
139 | PIM2 | 0.30732035 |
140 | PBK | 0.26225454 |
141 | ABL1 | 0.22596485 |
142 | CDK4 | 0.22106556 |
143 | PRKCD | 0.21529925 |
144 | PAK1 | 0.21308436 |
145 | INSR | 0.20607776 |
146 | RPS6KA6 | 0.18645490 |
147 | CLK1 | 0.17633458 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.99718682 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.80359138 |
3 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.78219805 |
4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.72016839 |
5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.69473528 |
6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.51084413 |
7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.37887520 |
8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.36336720 |
9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.35034949 |
10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.27815607 |
11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.22175420 |
12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.20168764 |
13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.15604408 |
14 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.12411875 |
15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.11771101 |
16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.06647923 |
17 | Leishmaniasis_Homo sapiens_hsa05140 | 2.05836125 |
18 | Asthma_Homo sapiens_hsa05310 | 2.03741165 |
19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.96955084 |
20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.93548845 |
21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.88685627 |
22 | Malaria_Homo sapiens_hsa05144 | 1.86598837 |
23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.86172251 |
24 | Tuberculosis_Homo sapiens_hsa05152 | 1.85324180 |
25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.81021134 |
26 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.79782865 |
27 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.79214529 |
28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.78372912 |
29 | Allograft rejection_Homo sapiens_hsa05330 | 1.78014468 |
30 | Salmonella infection_Homo sapiens_hsa05132 | 1.77776640 |
31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.77605182 |
32 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.75923701 |
33 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.71376786 |
34 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.68562347 |
35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.67593131 |
36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.61001546 |
37 | Other glycan degradation_Homo sapiens_hsa00511 | 1.60625269 |
38 | Phagosome_Homo sapiens_hsa04145 | 1.59275799 |
39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.58175190 |
40 | Peroxisome_Homo sapiens_hsa04146 | 1.57049892 |
41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.56808775 |
42 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.56289456 |
43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.54774988 |
44 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.53554238 |
45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.52396359 |
46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.48859116 |
47 | Bile secretion_Homo sapiens_hsa04976 | 1.48448861 |
48 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.48429446 |
49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.47304601 |
50 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.47069784 |
51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.43993148 |
52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.42758146 |
53 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.42724941 |
54 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.42530403 |
55 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.42281153 |
56 | Galactose metabolism_Homo sapiens_hsa00052 | 1.40771520 |
57 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.37707401 |
58 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.37607627 |
59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.36949064 |
60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.31183685 |
61 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.31156539 |
62 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.29343199 |
63 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.28746430 |
64 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.27447076 |
65 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.27007301 |
66 | Lysosome_Homo sapiens_hsa04142 | 1.26603344 |
67 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.25928883 |
68 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.25528901 |
69 | Influenza A_Homo sapiens_hsa05164 | 1.23053099 |
70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.22363624 |
71 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.21839194 |
72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.20770728 |
73 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.17860608 |
74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.16687491 |
75 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.15004547 |
76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.14201565 |
77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.13603750 |
78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.08796635 |
79 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.07156458 |
80 | Shigellosis_Homo sapiens_hsa05131 | 1.04220212 |
81 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.96627530 |
82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.93993942 |
83 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.92753518 |
84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.90671088 |
85 | ABC transporters_Homo sapiens_hsa02010 | 0.86807912 |
86 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.86350428 |
87 | Lysine degradation_Homo sapiens_hsa00310 | 0.81182764 |
88 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.77142768 |
89 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.77132004 |
90 | Mineral absorption_Homo sapiens_hsa04978 | 0.76226194 |
91 | Retinol metabolism_Homo sapiens_hsa00830 | 0.72443599 |
92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72442991 |
93 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.72417392 |
94 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72332875 |
95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72117795 |
96 | Apoptosis_Homo sapiens_hsa04210 | 0.71750203 |
97 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.68660486 |
98 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.68169026 |
99 | Sulfur relay system_Homo sapiens_hsa04122 | 0.67842706 |
100 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.67560142 |
101 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.67466761 |
102 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.66133200 |
103 | Prion diseases_Homo sapiens_hsa05020 | 0.63547581 |
104 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.63045318 |
105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.62393890 |
106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.62103135 |
107 | Hepatitis B_Homo sapiens_hsa05161 | 0.59925359 |
108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.59061983 |
109 | Insulin resistance_Homo sapiens_hsa04931 | 0.58471500 |
110 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.58362919 |
111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55788652 |
112 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.54324309 |
113 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.51250553 |
114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50608312 |
115 | Measles_Homo sapiens_hsa05162 | 0.50422364 |
116 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49043039 |
117 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.45492425 |
118 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.45217900 |
119 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44811573 |
120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43542038 |
121 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.42982230 |
122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42683960 |
123 | Bladder cancer_Homo sapiens_hsa05219 | 0.42242996 |
124 | Legionellosis_Homo sapiens_hsa05134 | 0.41996979 |
125 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.41951394 |
126 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41696727 |
127 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.41027213 |
128 | Endocytosis_Homo sapiens_hsa04144 | 0.40808195 |
129 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.40346747 |
130 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39671584 |
131 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.39277551 |
132 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.38002685 |
133 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.37022955 |
134 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.35613039 |
135 | Adherens junction_Homo sapiens_hsa04520 | 0.35453320 |
136 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.35026940 |
137 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.33856428 |
138 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33328390 |
139 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31921444 |
140 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.31591827 |
141 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.31549083 |
142 | Pertussis_Homo sapiens_hsa05133 | 0.30436817 |
143 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.28949399 |
144 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28794793 |
145 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.28196845 |
146 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.28173429 |
147 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.28013081 |
148 | Amoebiasis_Homo sapiens_hsa05146 | 0.27689869 |
149 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.27016592 |
150 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.25429107 |
151 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24900369 |
152 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.23217306 |
153 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22996449 |
154 | HTLV-I infection_Homo sapiens_hsa05166 | 0.22161395 |
155 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.21544537 |
156 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.20729674 |
157 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.20489468 |
158 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.20374153 |
159 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.19852496 |
160 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.19718449 |
161 | Tight junction_Homo sapiens_hsa04530 | 0.19060588 |
162 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.17737033 |
163 | Hepatitis C_Homo sapiens_hsa05160 | 0.17110747 |
164 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.17088069 |
165 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.16596980 |
166 | Focal adhesion_Homo sapiens_hsa04510 | 0.16294719 |